From October 1, 2023 to December 31, 2023, the company has repurchased 140,158 shares, representing 0.46% for $0.16 million. With this, the company has completed the repurchase of 4,848,678 shares, representing 14.76% for $15.58 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | -2.83% | -6.36% | -22.56% |
May. 13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
May. 09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.56% | 33.16M | |
-25.18% | 17.05B | |
-40.23% | 2.84B | |
+15.23% | 1.85B | |
-5.65% | 1.56B | |
+33.13% | 1.36B | |
-18.62% | 924M | |
-25.88% | 856M | |
-26.78% | 604M | |
+24.29% | 573M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.